EICHOR
● Completed
Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells
Condition: Vitiligo · Sponsor: Avita Medical
About this study
To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (17)
| Affiliated Dermatology | Scottsdale, Arizona, United States | — |
| University of California, Irvine | Irvine, California, United States | — |
| West Dermatology Research Center | San Diego, California, United States | — |
| Sutter Health | Sunnyvale, California, United States | — |
| California Dermatology Institute | Thousand Oaks, California, United States | — |
| Clarity Dermatology | Castle Rock, Colorado, United States | — |
| Siperstein Dermatology Group | Boynton Beach, Florida, United States | — |
| Skin Care Research, LLC | Hollywood, Florida, United States | — |
| Dermatologic Surgery Center of Washington | Chevy Chase, Maryland, United States | — |
| Maryland Laser, Skin & Vein Institute | Hunt Valley, Maryland, United States | — |
| University Of Massachusetts | Worcester, Massachusetts, United States | — |
| Hamzavi Dermatology | Canton, Michigan, United States | — |
+ 5 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05971381